Growth of rat mesangial cells on oxidized extracellular matrix increases inducible nitric oxide synthase activity

International Journal of Molecular Medicine

Volumn 3, Issue 3, 1999, Pages 323-327

  Trachtman, Howard ^a   Futterweit, Stephen ^a   Koss, Elana ^a   Bogart, Meredith ^a   Mermelstein, Art ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

Inducible nitric oxide synthase; Mesangium; Metal catalyzed oxidation

Indexed keywords

ARGININE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRITE; NOS2 PROTEIN, RAT; OXIDIZING AGENT; SCLEROPROTEIN;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; EXTRACELLULAR MATRIX; MESANGIUM; METABOLISM; OXIDATION REDUCTION REACTION; RAT; WESTERN BLOTTING;

ANIMALS; ARGININE; BLOTTING, WESTERN; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GLOMERULAR MESANGIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OXIDANTS; OXIDATION-REDUCTION; RATS;

EID: 0033085917     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.3.323     Document Type: Article

References (22)

1. Madri JA and Basson MD: Extracellular matrix-cell interaction: dynamic modulators of cell, tissue and organism structure and function. Lab Invest 66: 519-521, 1992.
2. Wells-Kenneth MC, Lyons TJ, McCance DR, Thorpe SR and Baynes JW: Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. J Clin Invest 100: 839-846, 1997.
3. Brownlee M: Glycation products and the complications of diabetic complications. Diabetes Care 15: 1835-1843, 1992.
4. Wolthius A, Boes A and Grond J: Cell density, modulates growth, extracellular matrix, and protein synthesis of cultured rat mesangial cells. Am J Pathol 143: 1209-1219, 1993.
5. Silbiger S, Crowley S, Shan Z, Brownlee M, Satriano J and Schlondorff D: Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge. Kidney Int 43: 853-846, 1993.
6. Mattana J, Margiloff L and Singhal PC: Oxidation of mesangial matrix using a mixed function oxidase system augments adhesion of macrophages: possible role of macrophage scavenger receptors. Biochem Biophys Res Commun 212: 63-69, 1995.
7. Trachtman H, Futterweit S and Crimmins DL: High glucose inhibits nitric oxide production in cultured rat mesangial cells. J Am Soc Nephrol 8: 1276-1282, 1997.
8. Baliga R, Ueda N, Walker PD and Shah SV: Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 29: 465-477, 1997.
9. Wasserman J, Santiago A, Rifici V, Holthofer H, Scharschmidt L, Epstein M and Schlondorff D: Interactions of low density lipoprotein with rat mesangial cells. Kidney Int 35: 1168-1174, 1989.
10. White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J and Freeman BA: Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 91: 1044-1048, 1994.
11. Tesfamariam B and Cohen RA: Free radicals mediate endothelial cell dysfunction caused by high glucose. Am J Physiol 263: H321-H326, 1992.
12. Bucala R, Tracey KJ and Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endotheliumdependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438, 1991.
13. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P and Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97: 22-28, 1996.
14. Nathan C and Xie QW: Regulation of biosynthesis of nitric oxide, J Biol Chem 269: 13725-13728, 1994.
15. Harrison DG: Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100: 2153-2157, 1997.
16. Colasanti M, Persichini T, Menagazzi M, Mariotto S, Giordano E, Caldarera CM, Sogos V, Lauro GM and Suzuki H: Induction of nitric oxide synthase mRNA expression: suppression by exogenous nitric oxide. J Biol Chem 270: 26731-26733, 1995.
17. Hagg PM, Hagg PO, Peltonen S, Autio-Hamainen H and Pihlajaniemi T: Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. Am J Pathol 150: 2075-2086, 1997.
18. Razzaque MS, Koji T, Harada T and Taguchi T: Identification of type VI collagen synthesizing cells in human diabetic glomerulosclerosis using renal biopsy sections. Anal Cell Pathol 15: 175-181, 1997.
19. Westberg G, Shultz PJ and Raij L: Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis in rats. Kidney Int 46: 711-716, 1994.
20. Morrissey JJ, Ishidoya S, McCracken R and Klahr S: Nitric oxide ameliorates the tubulointerstitial fibrosis of obstructive uropathy. J Am Soc Nephrol 7: 2201-2212, 1996.
21. Waddington S, Cook HT, Reaveley D, Jansen A and Cattell V: L-arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney Int 49: 1090-1096, 1996.
22. Narita I, Border WA, Ketteler M and Noble NA: Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 72: 17-24, 1995.